Clinical Decision Support System Now
Available for Medpod Users to Improve Patient Care
Henry Schein Medical, the U.S. medical business of Henry Schein,
Inc. and exclusive distributor of Medpod, Inc.’s telemedicine
solutions, announced today the integration of VisualDx - a clinical
decision support system - with Medpod’s technology infrastructure
to help health care professionals better diagnose patients
virtually.
VisualDx is designed to enhance diagnostic accuracy, aid
therapeutic decisions, and improve patient care, all critically
important to health care professionals on the front lines of
medicine.
“Henry Schein Medical is pleased to announce the expansion and
enhancement of the Medpod platform for our customers. With many
clinicians moving to a virtual care model, it’s imperative that
they are equipped with decision support technology to aid in
diagnostic and therapeutic decisions,” said Todd Stack, Senior
Director, Henry Schein Medical, who manages the exclusive
relationship with Medpod. “With Medpod, our customers can engage
with patients remotely to reduce exposure, and monitor at risk and
symptomatic patients remotely, which benefits both the patient and
practice.”
Medpod’s cloud-based software and modular infrastructure gives
providers and operators the ability to deliver customizable,
high-quality, and convenient care that meets the needs of patients
who cannot visit a traditional office setting. With the integration
of VisualDx’s clinical support, Medpod users can access a database
of information written by a variety of medical experts; recognize
disease variants; identify drug adverse events; and enhance patient
education to help provide informed, accurate, and fast
decision-making. The platform also assists users to make custom
diagnoses as a result of having the ability to enter
patient-specific information, such as age range, gender, symptoms
and signs; search by disease for quick therapy and treatment
options; review and compare a curated medical image library;
enhance understanding of medication reactions; and share patient
handouts via email. Clinicians can also earn Continuing Medical
Education (CME) credits each time they use VisualDx as part of
their subscription.
Available as one of Henry Schein Medical’s SolutionHub™ clinical
support solutions, VisualDx can support common and complex
diagnostic cases across medicine including rashes, variant
presentations of symptoms, and emerging infectious diseases. The
software is relevant for a range of health care specialties,
including: Family Medicine, Internal Medicine, Urgent Care,
Infectious Disease, Dermatology, Emergency Medicine, Pediatrics,
Risk Management, and Medical Education.
“We are excited to continue to enhance our relationship with
Henry Schein by offering this telemedicine integration to help aid
clinician decisions, drive quality care, and enhance diagnostic and
therapy decisions during the telemedicine encounter,” said Art
Papier, MD, CEO of VisualDx.
To learn more about third-party practice solutions available
from Henry Schein Medical, including Medpod, visit
https://www.henryscheinsolutionshub.com. To learn more about
VisualDx, visit www.visualdx.com/henryschein.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for
health care professionals powered by a network of people and
technology. With more than 19,000 Team Schein Members worldwide,
the Company's network of trusted advisors provides more than 1
million customers globally with more than 300 valued solutions that
improve operational success and clinical outcomes. Our Business,
Clinical, Technology, and Supply Chain solutions help office-based
dental and medical practitioners work more efficiently so they can
provide quality care more effectively. These solutions also
support dental laboratories, government and institutional
healthcare clinics, as well as other alternate care sites. Henry
Schein operates through a centralized and automated distribution
network, with a selection of more than 120,000 branded products and
Henry Schein private-brand products in stock, as well as more than
180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index,
Henry Schein is headquartered in Melville, N.Y., and has operations
or affiliates in 31 countries. The Company's sales from continuing
operations reached $10.0 billion in 2019, and have grown at a
compound annual rate of approximately 13 percent since Henry Schein
became a public company in 1995.
For more information, visit Henry Schein
at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein
on Twitter.
About VisualDx:
VisualDx is a Rochester, NY-based company dedicated to improving
healthcare decision making and reducing diagnostic errors. Its
professional product, VisualDx, is the award-winning diagnostic
clinical decision support system that has become the standard
professional resource at more than 2,300 hospitals worldwide and
over half the U.S. medical schools.
VisualDx, along with its consumer tool Aysa, combines problem
oriented clinical search with the world's best curated medical
image library, plus medical knowledge from experts and
sophisticated machine learning algorithms to help with differential
diagnosis, variation, treatment, and patient communication.
About Medpod Inc.
Medpod, Inc. is a software company that is revolutionizing the
delivery of care by removing long existing barriers and
facilitating high quality provider-to-patient and
provider-to-provider consultations, with telediagnostics. For more
information, visit www.medpodhealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200709005362/en/
Ann Marie Gothard Vice President, Corporate Media Relations
annmarie.gothard@henryschein.com (631) 390-8169
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From Apr 2023 to Apr 2024